News
Mary Beckerle is stepping down from her long tenure as CEO of Huntsman Cancer Institute at the University of Utah. Beckerle ...
The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...
Opinion
TEXAS VIEW: Could research funding cuts delay medical innovations that might save more lives?The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results